SH
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
$0.47 +0.00% (+$0.00)
Market Cap ¥4.61B
P/E Ratio 22.73x
Div. Yield 4.51%
ROE 1.67%
Bulios Fair Price
$0.61
29.9% upside
Trenutna cena
$0.47
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SHEZF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
78 /100
Cheap P/E 22.73x
P/B 0.39x
EV/EBITDA 11.90x
Growth
3 /100
Declining EPS growth 21.70%
Book val. growth 0.76%
Rev. growth 8.53%
Profitability
53 /100
Moderate Gross margin 33.33%
FCF margin 26.70%
Net margin 3.87%
Quality
8 /100
Poor ROIC 1.14%
Asset turnover 0.32x
ROE 1.67%
Debt
76 /100
Low Debt/Equity 0.24x
Net debt/EBITDA 2.73x
Current ratio 2.31x
Stability
35 /100
Moderate Beta 0.31x
Profitable years 2
Rev. volatility 14.43%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SHEZF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Li Li
Employees
1,926
Headquarters
Shenzhen